Blueprint Medicines Corporation
BPMC
$101.50
$1.161.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 496.00K | -49.96M | -56.27M | -50.00M | 89.14M |
| Total Depreciation and Amortization | 4.46M | 4.00M | 3.86M | 3.62M | 4.81M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.09M | 26.73M | 23.31M | 25.11M | -152.26M |
| Change in Net Operating Assets | -38.35M | -10.14M | 15.46M | -26.81M | -43.20M |
| Cash from Operations | -54.48M | -29.36M | -13.64M | -48.07M | -101.51M |
| Capital Expenditure | -1.83M | -932.00K | -25.00K | -2.57M | -1.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.91M | 34.64M | 29.98M | -185.72M | 78.24M |
| Cash from Investing | 65.08M | 33.71M | 29.95M | -188.29M | 77.13M |
| Total Debt Issued | -- | 0.00 | 0.00 | 146.97M | -- |
| Total Debt Repaid | -4.11M | 0.00 | 0.00 | -172.00K | -369.00K |
| Issuance of Common Stock | 13.30M | 9.76M | 18.38M | 31.21M | 67.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.19M | 9.76M | 18.38M | 178.01M | 66.96M |
| Foreign Exchange rate Adjustments | 661.00K | -1.32M | 591.00K | -31.00K | -145.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.45M | 12.78M | 35.28M | -58.38M | 42.44M |